Accentia Biopharmaceuticals, Inc. and its subsidiaries are committed to achieving significant long-term growth through: the research, development and commercialization of novel therapeutic drugs which target multi-billion dollar market opportunities; performing expert contract cell culture manufacturing services; marketing an innovative line of efficient, cost-effective advanced hollow fiber biomanufacturing systems; and providing a broad range of pharmaceutical consulting services through its subsidiary, Analytica International.

Together, these assets provide for a comprehensive ability to commercialize biopharmaceuticals.